Search Results - "Zlotta, Alex"

GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture by Jeyapala, Renu, Savio, Andrea J., Olkhov-Mitsel, Ekaterina, Kamdar, Shivani, Zhao, Fang, Cuizon, Carmelle, Liu, Richard S.C., Zlotta, Alex, Fleshner, Neil, van der Kwast, Theodorus, Bapat, Bharati

“…Tumor intraductal carcinoma/cribriform architecture (IDC/C) is associated with an unfavorable prognosis and biochemical recurrence (BCR) in prostate cancer…”
Get full text

Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting by Kassouf, Wassim, Aprikian, Armen, Saad, Fred, Fleshner, Neil, Alimohamed, Nimira, Breau, Rodney H, Brimo, Fadi, Chin, Joe, Chung, Peter, Cornacchia, Tony, Devins, Ferg, Eapen, Libni, Eigl, Bernie, Fairey, Adrian, Guttman, David, Izard, Jason P, Jacobsen, Niels, Jeldres, Claudio, Kulkarni, Girish, Lalani, Aly-Khan, Lodde, Michele, Lukka, Himu, Moore, Ron, Morash, Chris, North, Scott, Northam, Tammy, Ong, Michael, Power, Nick, Rendon, Ricardo, Purves, Robert, Shayegan, Bobby, Smith, Randy, So, Alan, Sridhar, Srikala S, Zlotta, Alex, Siemens, D Robert, Black, Peter C

Get full text

Improving patient journey and quality of care: Summary from the 2nd Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting by Kassouf, Wassim, Aprikian, Armen, Saad, Fred, Breau, Rodney H, Kulkarni, Girish, Guttman, David M, Bagshaw, Ken, Izawa, Jonathan, Eapen, Libni, Fairey, Adrian, So, Alan, North, Scott, Rendon, Ricardo, Sridhar, Srikala S, Brimo, Fadi, Chung, Peter, Drachenberg, Darrel, Fradet, Yves, Jacobsen, Niels, Morash, Chris, Shayegan, Bobby, Gotto, Geoffrey, Zlotta, Alex, Fleshner, Neil, Siemens, D Robert, Black, Peter C

Get full text

Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group by Northam, Tammy, Lukka, Himu, Saad, Fred, Devins, Ferg, North, Scott, Siemens, D. Robert, Moore, Ron, Zlotta, Alex, Jacobsen, Niels, Breau, Rodney H, Ong, Michael, Shayegan, Bobby, Izard, Jason P, Fleshner, Neil, Lalani, Aly-Khan, So, Alan, Guttman, David, Kulkarni, Girish, Cornacchia, Tony, Fairey, Adrian, Brimo, Fadi, Chung, Peter, Lodde, Michele, Morash, Chris, Alimohamed, Nimira, Smith, Randy, Purves, Robert, Aprikian, Armen, Chin, Joe, Eapen, Libni, Jeldres, Claudio, Kassouf, Wassim, Rendon, Ricardo, Black, Peter C, Eigl, Bernie, Sridhar, Srikala S, Power, Nick

Get full text

Continuing towards optimization of bladder cancer care in Canada: Summary of the 3rd BCC-CUA-CUOG bladder cancer quality of care consensus meeting by Kassouf, Wassim, Aprikian, Armen, Saad, Fred, Fleshner, Neil, AliMohamed, Nimira, Breau, Rodney H., Brimo, Fadi, Chin, Joe, Chung, Peter, Cornacchia, Tony, Devins, Ferg, Eapen, Libni, Eigl, Bernie, Fairey, Adrian, Guttman, David, Izard, Jason P., Jacobsen, Niels, Jeldres, Claudio, Kulkarni, Girish, Lalani, Aly-Khan, Lodde, Michele, Lukka, Himu, Moore, Ron, Morash, Chris, North, Scott, Northam, Tammy, Ong, Michael, Powers, Nick, Rendon, Ricardo, Purves, Robert, Shayegan, Bobby, Smith, Randy, So, Alan, Sridhar, Srikala, Zlotta, Alex, Siemens, D. Robert, Black, Peter C.

Get full text

Improving patient journey and quality of care: Summary from the 2nd Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group by Drachenberg, Darrel, Fradet, Yves, Saad, Fred, North, Scott, Siemens, D. Robert, Zlotta, Alex, Guttman, David M, Jacobsen, Niels, Breau, Rodney H, Shayegan, Bobby, Izawa, Jonathan, Fleshner, Neil, So, Alan, Kulkarni, Girish, Fairey, Adrian, Brimo, Fadi, Chung, Peter, Morash, Chris, Bagshaw, Ken, Gotto, Geoffrey, Aprikian, Armen, Eapen, Libni, Kassouf, Wassim, Rendon, Ricardo, Black, Peter C, Sridhar, Srikala S

Get full text

Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? by Djavan, B, Ravery, V, Zlotta, A, Dobronski, P, Dobrovits, M, Fakhari, M, Seitz, C, Susani, M, Borkowski, A, Boccon-Gibod, L, Schulman, C C, Marberger, M

“…We evaluated biochemical parameters and pathological features, as well as biopsy related morbidity of prostate cancer detected on biopsies 2, 3 and 4 in men…”
Get more information

Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European prostate cancer detection study by Djavan, Bob, Mazal, Peter, Zlotta, Alex, Wammack, Robert, Ravery, Vincent, Remzi, Mesut, Susani, Martin, Borkowski, Andrzej, Hruby, Stefan, Boccon-Gibod, Laurent, Schulman, Claude C., Marberger, Michael

“…BACKGROUND We evaluated pathological features of prostate cancer detected on repeat prostate biopsy in men with a serum total prostate‐specific antigen (PSA)…”
Get full text

Expert Opinion on Optimal Testosterone Control in Prostate Cancer by Zlotta, Alex, Debruyne, Frans M.J.

“…There are currently no definitions regarding “Optimal testosterone control in Prostate Cancer”. Therefore an Expert Consensus Meeting (May 22 2005, San…”
Get full text

Expert opinion on optimal testosterone control in prostate cancer: Expert report on optimising hormonal control in prostate cancer by ZLOTTA, Alex, DEBRUYNE, Frans M. J

Get full text